Pharmamarketeer

New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market

COVID-19 vaccine

The UK’s Drug Safety Research Unit (DSRU) and the University of Dundee’s Medicines Monitoring Unit (MEMO Research) have come together under the shadow of the ongoing pandemic to launch a new consortium to review the safety and efficacy of emerging vaccines to prevent COVID-19 infection.

The newly established Consortium for Monitoring the Safety and Effectiveness of COVID-19 Vaccines will conduct post-marketing studies of vaccine candidates in real time to identify any adverse events associated with lack of safety or efficacy as they occur, meaning action can then be promptly taken.

Image caption:  Image Credit: Greg Knobloch

read more

Medhc-fases-banner
Advertentie(s)